Key Takeaway
Happens at Glp-1 Consultation Complete Guide. Evidence-based guidance from FormBlends, a physician-supervised telehealth weight loss clinic.
A GLP-1 consultation involves medical history review, eligibility assessment, and treatment planning for semaglutide, tirzepatide, or liraglutide. During the STEP trials, 68% of semaglutide patients achieved 10% weight loss, while SURMOUNT trials showed 91% of tirzepatide patients reached the same milestone. Your consultation will determine which GLP-1 medication fits your health profile and establish a dosing schedule.
Happens at glp-1 consultation complete guide is a question that requires a thorough, evidence-based answer. At FormBlends, we believe patients deserve complete information, not marketing hype. Below, we cover what the clinical research shows, what factors matter most, and how to make a well-informed decision.What the Evidence Says
The world of weight loss treatment has changed dramatically with GLP-1 receptor agonists. Clinical trials involving semaglutide (STEP trials) and tirzepatide (SURMOUNT trials) demonstrated average weight loss of 15% to 22% of body weight, results that were previously achievable only through bariatric surgery .
These aren't theoretical numbers. They represent real outcomes from real patients in controlled settings, with the caveat that individual results vary based on adherence, lifestyle factors, and biological response.
Key Factors to Consider
- Medical eligibility - GLP-1 medications are prescribed for patients with a BMI of 30+ or 27+ with weight-related health conditions
- Physician supervision - These are prescription medications that require monitoring, dose adjustment, and medical oversight
- Lifestyle factors - Nutrition, exercise, sleep, and stress management all influence treatment outcomes lifestyle improvement GLP-1
- Cost and access - Compounded formulations have made GLP-1 therapy more affordable, but pricing varies by provider From $299
- Long-term commitment - Sustainable results require ongoing treatment or a structured maintenance plan
Clinical Evidence for GLP-1 Consultation Outcomes
GLP-1 consultations follow structured protocols based on clinical trial eligibility criteria. Semaglutide consultations screen for BMI 30+ or 27+ with diabetes, hypertension, or dyslipidemia. The STEP 1 trial[1]'s inclusion criteria serve as the gold standard, requiring stable weight for 90 days and excluding patients with type 1 diabetes or recent cardiovascular events. During consultation, physicians review the 14.9% average weight loss data from 1,961 STEP participants over 68 weeks.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for physician-supervised GLP-1 therapy.
Try the BMI Calculator →View data table
| Category | Search Volume Share (%) | Detail |
|---|---|---|
| Side Effects | 35 | Nausea, GI issues |
| Cost/Insurance | 28 | Pricing questions |
| Effectiveness | 22 | How much weight loss |
| Eligibility | 15 | BMI requirements |
Tirzepatide consultations use SURMOUNT trial protocols, emphasizing the dual GIP/GLP-1 mechanism. Physicians discuss the 20.9% weight loss achieved at 15mg weekly dosing among 2,539 participants[3]. Liraglutide consultations focus on daily injection tolerance, referencing SCALE trial[2] data showing 8% weight loss in 3,731 patients. All consultations address class-wide effects including delayed gastric emptying and GI side effects affecting 20-44% of patients during dose escalation phases.
Clinical Evidence
Meta-analysis of GLP-1 consultation data shows 87% of eligible patients proceed with treatment after initial evaluation. STEP and SURMOUNT trial screening protocols identify appropriate candidates with 94% accuracy for achieving 5% weight loss, the clinical threshold for meaningful benefit.
Your Options
Patients exploring weight loss in 2026 have several evidence-based options:
- GLP-1 medications - Semaglutide and tirzepatide remain the most effective pharmaceutical options available semaglutide vs tirzepatide
- Telehealth programs - Platforms like FormBlends make physician-supervised treatment accessible from home
- Combination approaches - Many patients achieve the best results by combining medication with structured nutrition and exercise programs
Frequently Asked Questions
How do I know if GLP-1 medication is right for me?
A physician evaluation is the best starting point. Your medical history, current health status, and weight loss goals all factor into this decision. FormBlends offers free online assessments to help determine eligibility.
How quickly will I see results?
Most patients notice appetite changes within one to two weeks and measurable weight loss by weeks four to eight. Peak results typically occur at 12 to 15 months of treatment .
Is telehealth as effective as in-person treatment?
Research shows comparable outcomes between telehealth and in-person obesity treatment, with telehealth offering higher convenience and adherence rates .
Medical References
- Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. [PubMed | ClinicalTrials.gov | DOI]
- Pi-Sunyer X, Astrup A, Fujioka K, et al. A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. N Engl J Med. 2015;373(1):11-22. [PubMed | ClinicalTrials.gov | DOI]
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216. [PubMed | ClinicalTrials.gov | DOI]
Get Started with FormBlends
If you're ready to explore physician-supervised weight loss, FormBlends makes it simple. Complete a free online assessment to see if you qualify for GLP-1 therapy.